Recruiting Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors NCT06176989 Conditions Chondrosarcoma, Cranial Nerve Diseases, Esthesioneuroblastoma, Olfactory, +26 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details
Completed Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma NCT01330966 Conditions Chondrosarcoma, Metastatic Chondrosarcoma, Neoplasms, +4 more Locations City of Hope — Duarte, California, United States Edward Cancer Center — Naperville, Illinois, United States University of Iowa — Iowa City, Iowa, United States Mayo Clinic — Rochester, Minnesota, United States View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting Vismodegib in Treating Patients With Advanced Chondrosarcomas NCT01267955 Conditions Chondrosarcoma, Chondrosarcoma, Clear Cell, Chondrosarcoma, Mesenchymal, +12 more Locations Institut Bergonie Cancer Center — Bordeaux, France Centre Oscar Lambert — Lille, France Centre Leon Berard — Lyon, France Hopital De La Timone — Marseille, France View more locations Show fewer locations Loading locations... View Trial Details
